Hemostatics
Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling hemorrhagic conditions.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), Hemostatics works in health care, medical, pharmaceutical, founded in 2020.
As a business in health care, medical, pharmaceutical, Hemostatics is listed here with the public details available about it.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Grant stage.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $1.3M.
| Sector | Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $1,300,000 |
Website: hemostatics.com
Sign in to view the contact information we hold for Hemostatics.
Create a free account
Create a free account